Oriola-KD Oyj (OKDBV):企業の財務・戦略的SWOT分析

◆英語タイトル:Oriola-KD Oyj (OKDBV) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C5345
◆発行会社(調査会社):GlobalData
◆発行日:2018年9月
◆ページ数:45
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フィンランド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Oriola-KD Oyj (OKDBV) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Oriola-KD Oyj (Oriola-KD) is a retail and wholesale company which distributes pharmaceuticals and health and wellbeing products. It offers expert advice on health and wellbeing and quality products through pharmacies. The company provides wide service offerings covering pharmaceutical distribution, branded products and other tailored services to healthcare operators. Its product portfolio includes vitamins, pharmaceutical cosmetics, skincare products, tests, dietary supplements, sports drinks, wound care products and other related products under Avene, Gefilus, Lysi and Oriola’s brands. It also provides pharmaceutical distribution services and a range of value adding services from clinical research to consumer services to pharmacies, pharma companies, veterinarians and grocery stores. Oriola-KD is headquartered in Espoo, Finland.

Oriola-KD Oyj Key Recent Developments

Jul 18,2018: Oriola: Half year financial report 1 January–30 June 2018
May 29,2018: Oriola: Management Changes
Mar 14,2018: Changes in Oriola´s Group Management team
Feb 13,2018: Oriolas Group Appoints Helena Kukkonen As Chief Financial Officer
Feb 13,2018: Oriola Financial Statements Release January-December 2017

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Section 1 – About the Company 6
Oriola-KD Oyj – Key Facts 6
Oriola-KD Oyj – Key Employees 7
Oriola-KD Oyj – Key Employee Biographies 8
Oriola-KD Oyj – Major Products and Services 9
Oriola-KD Oyj – History 10
Oriola-KD Oyj – Company Statement 11
Oriola-KD Oyj – Locations And Subsidiaries 12
Head Office 12
Other Locations & Subsidiaries 12
Section 2 – Company Analysis 13
Company Overview 13
Oriola-KD Oyj – Business Description 14
Business Segment: Consumer 14
Overview 14
Performance 14
Key Stats 14
Business Segment: Healthcare 14
Overview 14
Performance 14
Key Stats 14
Business Segment: Services 14
Overview 14
Performance 14
Geographical Segment: Finland 15
Performance 15
Geographical Segment: Other Countries 15
Performance 15
Geographical Segment: Sweden 15
Performance 15
Oriola-KD Oyj – Corporate Strategy 16
Oriola-KD Oyj – SWOT Analysis 17
SWOT Analysis – Overview 17
Oriola-KD Oyj – Strengths 17
Oriola-KD Oyj – Weaknesses 18
Oriola-KD Oyj – Opportunities 19
Oriola-KD Oyj – Threats 20
Oriola-KD Oyj – Key Competitors 21
Section 3 – Company Financial Ratios 22
Financial Ratios – Capital Market Ratios 22
Financial Ratios – Annual Ratios 23
Performance Chart 26
Financial Performance 26
Financial Ratios – Interim Ratios 27
Financial Ratios – Ratio Charts 28
Section 4 – Company’s Recent Developments 29
Jul 18, 2018: Oriola: Half year financial report 1 January–30 June 2018 29
May 29, 2018: Oriola: Management Changes 30
Mar 14, 2018: Changes in Oriola´s Group Management team 31
Feb 13, 2018: Oriola Financial Statements Release January-December 2017 32
Feb 12, 2018: Oriola’s new President and CEO joins the company 33
Jan 31, 2018: Recommendation by the Nomination Committee of Oriola concerning the Board of Directors to be elected by the 2018 Annual General Meeting 34
Dec 18, 2017: Robert Andersson appointed Oriola new President and CEO 36
Dec 18, 2017: Oriola’s President and CEO to change 37
Dec 18, 2017: Oriola specifies the outlook for 2017 38
Oct 25, 2017: Oriola: Interim Report January-September 2017 39
Section 5 – Appendix 41
Methodology 41
Ratio Definitions 41
About GlobalData 45
Contact Us 45
Disclaimer 45

List of Tables
Oriola-KD Oyj, Key Facts 6
Oriola-KD Oyj, Key Employees 7
Oriola-KD Oyj, Key Employee Biographies 8
Oriola-KD Oyj, Major Products and Services 9
Oriola-KD Oyj, History 10
Oriola-KD Oyj, Subsidiaries 12
Oriola-KD Oyj, Key Competitors 21
Oriola-KD Oyj, Ratios based on current share price 22
Oriola-KD Oyj, Annual Ratios 23
Oriola-KD Oyj, Annual Ratios (Cont...1) 24
Oriola-KD Oyj, Annual Ratios (Cont...2) 25
Oriola-KD Oyj, Interim Ratios 27
Currency Codes 41
Capital Market Ratios 41
Equity Ratios 42
Profitability Ratios 42
Cost Ratios 43
Liquidity Ratios 43
Leverage Ratios 44
Efficiency Ratios 44

List of Figures
Oriola-KD Oyj, Performance Chart (2013 - 2017) 26
Oriola-KD Oyj, Ratio Charts 28

★海外企業調査レポート[Oriola-KD Oyj (OKDBV):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • The Norinchukin Bank:企業の戦略・SWOT・財務分析
    The Norinchukin Bank - Strategy, SWOT and Corporate Finance Report Summary The Norinchukin Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Monitise plc:企業のM&A・事業提携・投資動向
    Monitise plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Monitise plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • Bone Solutions Inc-医療機器分野:企業M&A・提携分析
    Summary Bone Solutions Inc (BSI) is a medical device company that offers orthobiologics technology solutions. The company also develops magnesium oxide based technologies for multitude of orthopedic applications. It offers osteocrete bone graft substitute that provides adhere ligaments and tendons t …
  • Bank of Nanjing Co., Ltd.:戦略・SWOT・企業財務分析
    Bank of Nanjing Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Bank of Nanjing Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Nuvaira Inc:医療機器:M&Aディール及び事業提携情報
    Summary Nuvaira Inc (Nuvaira), formerly Holaira Inc is an independent medical device company that strives to develop minimally invasive products for the treatment of obstructive lung diseases. It provides Lung Denervation System, a catheter-based system intended for asthma and chronic obstructive pu …
  • Pan American Silver Corp:企業の戦略・SWOT・財務分析
    Pan American Silver Corp - Strategy, SWOT and Corporate Finance Report Summary Pan American Silver Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Air Liquide SA (AI):企業の財務・戦略的SWOT分析
    Air Liquide SA (AI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Polyplex (Thailand) Public Company Limited:企業の戦略・SWOT・財務情報
    Polyplex (Thailand) Public Company Limited - Strategy, SWOT and Corporate Finance Report Summary Polyplex (Thailand) Public Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, …
  • Frontken Corporation Berhad (FRONTKN):企業の財務・戦略的SWOT分析
    Summary Frontken Corporation Berhad (Frontken) is a construction and industrial equipment provider. The company’s products include valves, motors, generators, pumps, transformers, turbines, compressors, diesel engines, steel rolls and boiler tubes. It offers services including thermal spray coating, …
  • Veolia Environnement S.A.:企業の戦略・SWOT・財務分析
    Veolia Environnement S.A. - Strategy, SWOT and Corporate Finance Report Summary Veolia Environnement S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Aurora Spine Corp (ASG):企業の製品パイプライン分析2018
    Summary Aurora Spine Corp (Aurora) is a medical equipment provider that offers surgical tools. The company offers novel solutions in the spinal implant market through a range of minimally invasive, and regenerative spinal implant technologies. It develops and distributes spinal implant products whic …
  • Greif, Inc. (GEF):企業の財務・戦略的SWOT分析
    Greif, Inc. (GEF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • VolitionRX Ltd (VNRX):企業の財務・戦略的SWOT分析
    Summary VolitionRX Ltd (VolitionRX) is a medical equipment provider that develops diagnostics tests for cancer and other conditions. The company develops Nucleosomics, a platform technology used for measurement and identification of nucleosomes in the blood. It develops tools for the diagnosis of va …
  • Dunkin’ Brands Group Inc:企業の戦略・SWOT・財務情報
    Dunkin' Brands Group Inc - Strategy, SWOT and Corporate Finance Report Summary Dunkin' Brands Group Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Puncak Niaga Holdings Bhd (PUNCAK):企業の財務・戦略的SWOT分析
    Puncak Niaga Holdings Bhd (PUNCAK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Guardant Health Inc (GH):企業の製品パイプライン分析2018
    Summary Guardant Health Inc (Guardant Health) is a non-invasive cancer diagnostics company that commercializes genomic liquid biopsy. The company develops proprietary digital sequencing technology used to detect individual genomic alterations. It offers Guardant360, a tool for early cancer detection …
  • ET Solar Group Corporation-エネルギー分野:企業M&A・提携分析
    Summary ET Solar Group Corporation (ET Solar) is a provider of renewable energy equipment and services. The company produces a wide variety of photovoltaic (PV) modules based on global standards such as IEC, TUV, VDE, and UL. It also provides horizontally integrated project development; finance and …
  • Cold Spring Harbor Laboratory:製薬・医療:M&Aディール及び事業提携情報
    Summary Cold Spring Harbor Laboratory (CSHL) is a research and education institution that offers molecular biology and genetics services. The institution offers research services such as graduate research, research training, clinical research, quantitative biology research, postdoctoral research, di …
  • Empresa Electricidad del Peru SA (ELECPBC1):企業の財務・戦略的SWOT分析
    Empresa Electricidad del Peru SA (ELECPBC1) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key streng …
  • Stellar Biotechnologies Inc (SBOT)-医療機器分野:企業M&A・提携分析
    Summary Stellar Biotechnologies Inc (Stellar Bio), formerly CAG Capital Inc is a provider of keyhole limpet hemocyanin proteins. The company offers potent immune-stimulating molecule used as an active pharmaceutical ingredient known as active immunotherapies or therapeutic vaccines and as an injecta …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆